Abstract
Background: The transcription factor T-bet is a critical regulator of Th1 effector function. Animals deficient in T-bet are protected from a variety of inflammatory diseases, including systemic lupus erythematosus and inflammatory arthritis. An essential function of Th1 cells is the ability to traffic appropriately to sites of inflammation, which is largely dependent on the expression of specific selectin ligands and chemokine receptors. We therefore hypothesised that T-bet would modulate lymphocyte trafficking in vitro and in vivo by direct regulation of both selectin binding and chemokine function. Methods: Balb/c mice deficient in, or transgenic for, T-bet had been generated previously. T-bet\(^{-/-}\) × DO11.10 TCR and T-bet\(^{-/-}\) × IFN\(^{-/-}\) mice were generated by backcrossing for >10 generations. CD4\(^+\) T cells were generated from primary lymph nodes from all these mice by positive selection and stimulation with appropriate antigen. Functional analysis used the following four methods: adoptive transfer into WT Balb/c mice, which were then injected with OVA, cells were harvested from the spleen, lymph node and peritoneum; selectin binding, interactions with immoblised P-selectin and E-selectin under conditions of laminar flow were examined in a parallel plate flow chamber; expression of selectin ligands, using flow cytometry, real-time PCR and 35S incorporation; and chemokine receptor expression and function, using flow cytometry, real-time PCR, transwell chemotaxis and endothelial binding under flow conditions. Results: Selective migration of T-bet\(^{-/-}\) CD4\(^+\) T cells in a Th1-dependent model of peritoneal inflammation was completely abrogated. Further investigation revealed that this effect was due to a 50% reduction in binding to P-selectin but not E-selectin under in vitro flow conditions and that this was as a result of impaired tyrosine sulfation of PSGL-1. In addition, mRNA and surface expression of CXCR3, but not CCR5, was reduced and this was associated with a reduction in both transwell chemotaxis and binding to endothelial cells. Retroviral transfer experiments of T-bet cDNA into T-bet\(^{-/-}\) and T-bet\(^{-/-}\) × IFN\(^{-/-}\) cells demonstrated that these effects were independent of interferon. Conclusions: These data establish that T-bet imprints a specific migratory program onto developing CD4\(^+\) cells via control of PSGL-1 sulfation (and thus P-selectin binding) and CXCR3 expression and function. Furthermore, as E-selectin and CCR5 binding are unimpaired, this reveals a level of control on trafficking of Th1 lymphocytes not recognised by previous paradigms.
Highlights
Antibodies to citrullinated proteins are the most specific serological marker for rheumatoid arthritis (RA)
Antigen-specific, but not non-specific, B cells acquired antigen and produced peptide–MHC II complexes by 6 hours. These B cells migrated from random positions in the follicles to the border with the T-cell area, and interacted stably there with peptide–MHC II-specific CD4+ T cells by about 36 hours. These results demonstrate the antigen-specific CD4+ T cells interact with a variety of antigen-presenting cell types during the primary immune response
Providing a link between altered apoptosis and cartilage destruction, we have shown that overexpression of TIMP-3 through gene transfer reduces the invasiveness of rheumatoid arthritis synovial fibroblasts (RASF) and moduinflammatory joint disease lates the apoptosis-inhibiting effects of tumour necrosis factor (TNF)-α
Summary
Antibodies to citrullinated proteins are the most specific serological marker for rheumatoid arthritis (RA). We have compared the stability of induced IL-2 mRNA, and the regulation of transcription factors important for IL-2 gene expression, in control and TNF-treated cells; and we have recently begun to study effects of chronic TNF on chromatin remodelling across the IL-2 proximal promoter (pIL-2), which precedes initiation of transcription, using the chromatin accessibility real-time PCR (CHART-PCR) assay [3]. We examined a cohort of patients with rheumatoid arthritis whose disease was well controlled, and where we had previously shown that heterogeneous circulating levels of IL-7 positively correlated with thymic activity, to investigate the role of IL-7 on the function of CD4+CD25high T cells. Recent data indicate that bone marrow in rheumatoid arthritis (RA) patients may actively participate in the pathogenesis of RA as a secondary lymphoid organ via overproduction of proinflammatory cytokines and a site of effective antigen presentation.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have